Schizophrenia/Catatonia in Individuals with Autism Spectrum Disorder
2018-2019 START National Online Training Series
Presentation Title: Schizophrenia/Catatonia in Individuals with Autism Spectrum Disorder
Presenter: Jennifer McLaren, MD, Assistant Professor of Psychiatry, Dartmouth Institute at the Geisel School of Medicine at Dartmouth
Dr. McLaren will discuss the history of autism, schizophrenia and catatonia. She will review the DSM-5 criteria, prevalence of these disorders, risk factors and overlapping features of schizophrenia and autism. She will discuss the presentation of schizophrenia and autism and briefly review treatment. Dr. McLaren will review how catatonia presents in individuals with autism and the treatment.
- Discuss history of autism, schizophrenia and catatonia
- Review DSM-5 criteria, epidemiology, risk factors, and overlapping features of autism and schizophrenia.
- Discuss the presentation of schizophrenia in autism
- Review DSM-5 criteria, presentation and treatment of catatonia in individuals with autism
About the Presenter:
Jennifer McLaren, M.D. is an Assistant Professor of Psychiatry and The Dartmouth Institute at the Geisel School of Medicine at Dartmouth. Dr. McLaren specializes in child and adolescent psychiatry, particularly in autism spectrum disorders and developmental disabilities.
Improving the quality of life for people with autism spectrum disorders and developmental disabilities has been the defining purpose of Dr. McLaren’s career. Dr. McLaren’s work has focused on clinical program development, education, health policy, and research. Dr. McLaren oversees the Behavioral and Neurodevelopmental Services (BANDS) at Dartmouth-Hitchcock Medical Center. BANDS is a multidisciplinary group of providers at Dartmouth-Hitchcock who work with children, adolescents, and young adults and their families dealing with Autism Spectrum and other neurodevelopmental disorders. Dr. McLaren is the director of the supported employment program for people with autism and developmental disabilities at Dartmouth-Hitchcock Medical Center. Dr. McLaren is also the medical director for the Bureau of Developmental Services in New Hampshire and for NH START. Dr. McLaren has received awards for clinical and teaching excellence.
Dr. McLaren is a member of the Vulnerable Children’s Research Group at The Dartmouth Institute, which aims to improve mental health and social services for vulnerable children and their families through research, policy, partnerships with people with lived experience, and clinical services.
Resources & References:
American Psychiatric Association (2013). Diagnostic and stastical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Association.
Cauda, F., Costa, T., Nani, A., Fava, L., Palermo, S., Bianco, F., . . . Keller, R. (2017). Are schizophrenia, autistic, and obsessive spectrum disorders dissociable on the basis of neuroimaging morphological findings?: A voxel-based meta-analysis. Autism Res, 10(6), 1079-1095. doi:10.1002/aur.1759
Costanzo, F., Menghini, D., Casula, L., Amendola, A., Mazzone, L., Valeri, G., & Vicari, S. (2015). Transcranial Direct Current Stimulation Treatment in an Adolescent with Autism and Drug-Resistant Catatonia. Brain Stimul, 8(6), 1233-1235. doi:10.1016/j.brs.2015.08.009
Larson, F. V., Wagner, A. P., Jones, P. B., Tantam, D., Lai, M. C., Baron-Cohen, S., & Holland, A. J. (2017). Psychosis in autism: comparison of the features of both conditions in a dually affected cohort. Br J Psychiatry, 210(4), 269-275. doi:10.1192/bjp.bp.116.187682
Le Gall, E., & Iakimova, G. (2018). [Social cognition in schizophrenia and autism spectrum disorder: Points of convergence and functional differences]. Encephale. doi:10.1016/j.encep.2018.03.004
Mazzone, L., Postorino, V., Valeri, G., & Vicari, S. (2014). Catatonia in patients with autism: prevalence and management. CNS Drugs, 28(3), 205-215. doi:10.1007/s40263-014-0143-9
Morrison, K. E., Pinkham, A. E., Penn, D. L., Kelsven, S., Ludwig, K., & Sasson, N. J. (2017). Distinct profiles of social skill in adults with autism spectrum disorder and schizophrenia. Autism Res, 10(5), 878-887. doi:10.1002/aur.1734
Paval, D. (2017). A Dopamine Hypothesis of Autism Spectrum Disorder. Dev Neurosci, 39(5), 355-360. doi:10.1159/000478725
Pinkham, A. E., Sasson, N. J., Beaton, D., Abdi, H., Kohler, C. G., & Penn, D. L. (2012). Qualitatively distinct factors contribute to elevated rates of paranoia in autism and schizophrenia. J Abnorm Psychol, 121(3), 767-777. doi:10.1037/a0028510
Raja, M., & Azzoni, A. (2009). Thought disorder in Asperger syndrome and schizophrenia: issues in the differential diagnosis. A series of case reports. World J Biol Psychiatry, 10(4 Pt 3), 944-952. doi:10.1080/15622970701687303
Sasson, N. J., Pinkham, A. E., Weittenhiller, L. P., Faso, D. J., & Simpson, C. (2016). Context Effects on Facial Affect Recognition in Schizophrenia and Autism: Behavioral and Eye-Tracking Evidence. Schizophr Bull, 42(3), 675-683. doi:10.1093/schbul/sbv176
Wachtel, L. E. (2018). The multiple faces of catatonia in autism spectrum disorders: descriptive clinical experience of 22 patients over 12 years. Eur Child Adolesc Psychiatry. doi:10.1007/s00787-018-1210-4
Wachtel, L. E., Shorter, E., & Fink, M. (2018). Electroconvulsive therapy for self-injurious behaviour in autism spectrum disorders: recognizing catatonia is key. Curr Opin Psychiatry, 31(2), 116-122. doi:10.1097/yco.0000000000000393
Zheng, Z., Zheng, P., & Zou, X. (2018). Association between schizophrenia and autism spectrum disorder: A systematic review and meta-analysis. Autism Res, 11(8), 1110-1119. doi:10.1002/aur.1977
Zhou, Y., Kaiser, T., Monteiro, P., Zhang, X., Van der Goes, M. S., Wang, D., . . . Feng, G. (2016). Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects. Neuron, 89(1), 147-162. doi:10.1016/j.neuron.2015.11.023